Comparative efficacy and safety of insulin analogs in hospitalized adults.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  American Journal of Health-System Pharmacy

• Publication date

  2015-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.2146/ajhp140161PMID 25788506
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses

  2014cited by this paper
• Canadian Diabetes Association 2013 clinical practice guidelines for the prevention and management of diabetes in Canada. Introduction.

  2013cited by this paper
• Canadian Diabetes Association Clinical Practice Guidelines Expert Committee

  2013cited by this paper
• Glucose Control in Acute Myocardial Infarction: A Pilot Randomized Study Controlled by Continuous Glucose Monitoring System Comparing the Use of Insulin Glargine with Standard of Care

  2012cited by this paper
• A Critical Appraisal of the Role of Insulin Analogues in the Management of Diabetes Mellitus

  2012cited by this paper
• Basal–bolus insulin versus sliding‐scale insulin for inpatient glycaemic control: a clinical practice comparison

  2012cited by this paper
• Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials

  2011cited by this paper
• GRADE guidelines: 3. Rating the quality of evidence.

  2011cited by this paper
• GRADE guidelines: 7. Rating the quality of evidence--inconsistency.

  2011cited by this paper
• GRADE guidelines 6. Rating the quality of evidence--imprecision.

  2011cited by this paper
• Managing diabetic ketoacidosis in non-intensive care unit setting: Role of insulin analogs

  2011cited by this paper
• Insulin injections in relation to meals in the hospital medicine ward: comparison of 2 protocols.

  2011cited by this paper
• A review of modern insulin analogue pharmacokinetic and pharmacodynamic profiles in type 2 diabetes: improvements and limitations

  2011cited by this paper
• GRADE guidelines: 8. Rating the quality of evidence--indirectness.

  2011cited by this paper
• Comparison of 70/30 biphasic insulin with glargine/lispro regimen in non-critically ill diabetic patients on continuous enteral nutrition therapy.

  2011cited by this paper
• Randomized Study of Basal-Bolus Insulin Therapy in the Inpatient Management of Patients With Type 2 Diabetes Undergoing General Surgery (RABBIT 2 Surgery)

  2011cited by this paper
• Evaluation of the Cost-Effectiveness of Different Insulin Regimes during the Peri- Operative Period in Type-2 Diabetics in India

  2011cited by this paper
• Glulisine Versus Human Regular Insulin in Combination With Glargine in Noncritically Ill Hospitalized Patients With Type 2 Diabetes

  2010cited by this paper
• Does type of bolus insulin matter in the hospital? Retrospective cohort analysis of outcomes between patients receiving analogue versus human insulin.

  2010cited by this paper
• Effects of moderate intensity glycemic control after cardiac surgery.

  2010cited by this paper
• Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

  2009cited by this paper
• Insulin Analogs Versus Human Insulin in the Treatment of Patients With Diabetic Ketoacidosis

  2009cited by this paper
• An evidence-based practice guideline for the peer review of electronic search strategies.

  2009cited by this paper
• Evaluation of glycemic control using NPH insulin sliding scale versus insulin aspart sliding scale in continuously tube-fed patients.

  2009cited by this paper
• Efficacy and safety of insulin analogues for the management of diabetes mellitus: a meta-analysis

  2009cited by this paper
• Glycaemic control in type 2 diabetes mellitus patients undergoing major surgery: comparison of three subcutaneous insulin regimens.

  2009cited by this paper
• Comparison of inpatient insulin regimens with detemir plus aspart versus neutral protamine hagedorn plus regular in medical patients with type 2 diabetes.

  2009cited by this paper
• Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement

  2009cited by this paper
• Inpatient glycemic control on the vascular surgery service.

  2008cited by this paper
• Assessing Risk of Bias in Included Studies

  2008cited by this paper
• Insulin glargine improves glycaemic control after coronary surgery in patients with diabetes or pre-diabetes

  2008cited by this paper
• Randomized Study of Basal-Bolus Insulin Therapy in the Inpatient Management of Patients With Type 2 Diabetes (RABBIT 2 Trial)

  2008cited by this paper
• Long-acting insulin analogues for diabetes mellitus: meta-analysis of clinical outcomes and assessment of cost-effectiveness

  2007cited by this paper
• Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus.

  2007cited by this paper
• Once-daily insulin glargine versus 6-hour sliding scale regular insulin for control of hyperglycemia after a bariatric surgical procedure: a randomized clinical trial.

  2007cited by this paper
• Efficacy of short term continuous subcutaneous insulin lispro versus continuous intravenous regular insulin in poorly controlled, hospitalized, type 2 diabetic patients.

  2006cited by this paper
• Comparison of Once-Daily Glargine Insulin with Twice-Daily NPH/Regular Insulin for Control of Hyperglycemia in Inpatients After Cardiovascular Surgery

  2006cited by this paper
• Glycemic control with regular versus lispro insulin sliding scales in hospitalized Type 2 diabetics.

  2006cited by this paper
• Treatment of diabetic ketoacidosis with subcutaneous insulin aspart.

  2004cited by this paper
• Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis.

  2004cited by this paper

• Prandial Insulins: A Person-Centered Choice

  2024cites this paper
• Clinical outcomes of intensive care unit patients infected with multidrug-resistant gram-negative bacteria treated with ceftazidime/avibactam and ceftolozane/tazobactam

  2023cites this paper
• Pharmacists' role in glycemic management in the inpatient setting: An opinion of the endocrine and metabolism practice and research network of the American College of Clinical Pharmacy

  2018cites this paper